5-Beta-Tetrahydrocorticosterone (5b-THB) is a key metabolite of corticosterone, a corticosteroid produced in the adrenal cortex from cholesterol.
5b-THB is formed by the action of 5β-reductase enzymes primarily in the liver and plays a crucial role in the metabolism of corticosterone.
Unlike its 5α-reduced counterpart, 5b-THB binds minimally to glucocorticoid receptors, indicating limited biological activity. However, monitoring the levels of 5b-THB in urine can provide valuable insights into adrenal function and the activity of steroidogenic enzymes, making it a significant biomarker for diagnosing and understanding metabolic and endocrine disorders.
Elevated or decreased levels of 5b-THB can signal various conditions such as Cushing's syndrome, adrenal hyperplasia, or Addison’s disease, thus emphasizing its clinical importance in evaluating adrenal health and hormonal imbalances.
Along with 5a-tetrahydrocorticosterone, 5b-tetrahydrocorticosterone (5b-THB) is one of the terminal metabolites of corticosterone. Corticosterone is a corticosteroid, which is a steroid hormone produced from cholesterol in the adrenal cortex.
5β-tetrahydrocorticosterone and 5α-tetrahydrocorticosterone are stereoisomers, differing in the configuration of the hydrogen atoms at the 5th carbon position of the steroid backbone.
5β-tetrahydrocorticosterone and 5α-tetrahydrocorticosterone are metabolites of corticosterone, but they are produced by different enzymes.
5β-tetrahydrocorticosterone is formed by the action of 5β-reductase enzymes on corticosterone, while 5α-tetrahydrocorticosterone is formed by the action of 5α-reductase enzymes on corticosterone.
5b-tetrahydrocorticosterone (5b-THB) is a metabolite derived from corticosterone through the action of 5b-reductase (AKR1D1) and subsequent steps involving 3α-hydroxysteroid dehydrogenase (HSD3B) and 3b-hydroxysteroid dehydrogenase (AKR1C1/C2). [10.]
5b-Reductase is primarily expressed in the liver and to a lesser extent in the testis and colon. [8.]
5b-tetrahydrocorticosterone (5b-THB) binds minimally to glucocorticoid receptors compared to corticosterone and 5a-reduced metabolites. [9.]
These 5b-reduced metabolites did not activate glucocorticoid receptors in cell assays and showed lower binding affinities, suggesting limited biological activity. [9.] This lack of GR activation by 5b-THB contrasts with the activity seen in 5α-reduced glucocorticoid metabolites.
5b-THB is a significant urinary metabolite that can be used to assess steroidogenic activity and enzyme functions, especially when assessed with 5a-tetrahydrocorticosterone and other adrenal hormone metabolites.
The presence and levels of 5b-THB in urine provide insights into the metabolic pathways active in steroid hormone metabolism, especially those involving corticosterone.
Monitoring 5b-THB levels in urine is relevant for understanding various metabolic disorders and enzyme deficiencies. Along with other steroid hormone metabolites, it serves as a biomarker for disorders affecting steroidogenesis and can help diagnose enzyme deficiencies such as 5b-reductase deficiency.
It is important to understand the differential presence of 5b-THB in serum and urine, illustrating how the steroid metabolomes in these biological fluids can provide complementary information. While 5b-THB is a prominent urinary metabolite, its presence in serum is less pronounced, underscoring the importance of urinary analysis for specific steroid metabolites.
The production and levels of 5b-Tetrahydrocorticosterone are influenced by various factors, including:
ACTH, released by the pituitary gland, is a key regulator of adrenal steroidogenesis, including the synthesis of cortisol and its metabolites.
The biosynthesis of adrenal steroids and their metabolites, including 5b-Tetrahydrocorticosterone, exhibits a diurnal pattern.
Steroid hormone levels, including those of 5b-Tetrahydrocorticosterone, can vary depending on age and developmental stage, such as during fetal development, childhood, and aging.
Variations in genes encoding enzymes involved in steroidogenesis, such as CYP11B1 and AKR1D1, can influence the production and levels of 5b-Tetrahydrocorticosterone.
Certain diseases and disorders affecting adrenal hormones such as adrenal hyperplasia, Cushing's syndrome, adrenal insufficiency including Addison’s disease, or congenital adrenal hyperplasia, can lead to altered levels of 5b-Tetrahydrocorticosterone and other steroid metabolites.
Altered levels may also be seen in PCOS, as it may alter the enzymatic function of the 5-alpha and 5-beta reductase enzymes. [2.]
Cortisol metabolites such as 5b-THB are often tested in the urine, commonly over 24 hours. They may also be tested in the blood.
It is important to consult with the ordering provider regarding preparation for sample collection, as certain supplements or medications may need to be avoided.
It is important to assess levels of adrenal hormones in the broader context of overall hormone levels; imbalances may signal a genetic or functional issue affecting hormone production or metabolism.
Additionally, interpretation should take into account the presence of any symptoms of hormone excess or deficiency.
One lab reports the following optimal levels for 5b-THB: 58-240 ng/mg Creatinine/Day. [13.]
Elevated levels of 5b-THB can be seen in conditions associated with increased cortisol production and adrenal activity, including Cushing syndrome as well as elevated cortisol output in stress or inflammation. [3., 17.]
Chronic or excessive alcohol use can also raise cortisol levels and, therefore, its metabolites including 5b-THB. [14.]
Decreased levels of 5b-THB may signal decreased cortisol output due to Addison’s disease, adrenal insufficiency, or congenital adrenal hyperplasia. [1., 12., 16.]
Cortisol, the primary glucocorticoid hormone produced by the adrenal glands, is closely related to 5b-THB in terms of biosynthesis and metabolism.
Measuring cortisol levels alongside 5b-THB can provide valuable insights into adrenal function and the regulation of the hypothalamic-pituitary-adrenal (HPA) axis.
Other adrenal hormones, such as aldosterone and dehydroepiandrosterone (DHEA), may also be evaluated in conjunction with 5b-THB to assess adrenal disorders.
Several steroid metabolites including tetrahydrocortisone (THE) and tetrahydrocortisol (THF), are closely related to 5b-THB and may serve as complementary biomarkers.
These metabolites are formed through similar enzymatic pathways and can provide additional information about steroid metabolism and potential dysregulation in various disease states.
The FAQ section addresses common questions and concerns about 5β-Tetrahydrocorticosterone, providing clear and concise answers for better understanding.
5β-Tetrahydrocorticosterone is a metabolite of corticosterone, a steroid hormone produced by the adrenal glands. It plays a role in the metabolism of corticosterone and is involved in the regulation of stress responses and immune function.
5β-Tetrahydrocorticosterone is important because it serves as an indicator of adrenal gland function and corticosterone metabolism. Abnormal levels can provide insights into various health conditions related to adrenal and endocrine function.
5β-Tetrahydrocorticosterone functions as a metabolite in the corticosterone metabolism pathway. It does not have any biological activity, but monitoring its levels may provide insight into endocrine imbalances or pathologies.
5β-Tetrahydrocorticosterone levels are typically measured through urine tests, often involving a 24-hour urine collection. Blood tests may also be used, but urine tests are more common for assessing steroid metabolites.
Normal levels of 5β-Tetrahydrocorticosterone can vary depending on factors such as age, sex, and overall health. Reference ranges are provided by the testing laboratory and should be interpreted by a healthcare provider in the context of the patient's health status and medical history.
Elevated levels of 5β-Tetrahydrocorticosterone can be caused by conditions such as adrenal hyperplasia, Cushing's syndrome, and chronic stress. These conditions lead to increased production and metabolism of corticosterone.
Low levels of 5β-Tetrahydrocorticosterone may indicate adrenal insufficiency, Addison's disease, or dysfunction in the enzymes involved in steroid metabolism. These conditions result in reduced production or impaired metabolism of corticosterone.
Symptoms of abnormal 5β-Tetrahydrocorticosterone levels can vary depending on whether levels are high or low.
High levels may lead to symptoms such as weight gain, high blood pressure, fatigue, and muscle weakness.
Low levels can cause symptoms like weight loss, low blood pressure, fatigue, and darkening of the skin.
Treatment for abnormal levels of 5β-Tetrahydrocorticosterone depends on the underlying cause.
Common approaches include hormone replacement therapy, medications to regulate adrenal gland function, and lifestyle changes to manage stress.
It is essential to consult with a healthcare provider to develop an appropriate treatment plan based on individual health needs.
A doctor might order a 5β-Tetrahydrocorticosterone test to evaluate adrenal gland function, diagnose disorders related to corticosterone metabolism such as Cushing's syndrome or Addison's disease, and monitor the body's response to stress.
It can also be part of a comprehensive hormonal evaluation for patients with symptoms of adrenal imbalance.
Yes, the 5β-Tetrahydrocorticosterone test is safe. The most common risk associated with the test is slight discomfort or inconvenience from the 24-hour urine collection process.
Blood tests, if used, may cause slight discomfort or bruising at the site where blood is drawn.
Click here to compare testing options and order testing for 5b-THB.
[1.] Adrenal Insufficiency - Hormonal and Metabolic Disorders. Merck Manuals Consumer Version. https://www.merckmanuals.com/home/hormonal-and-metabolic-disorders/adrenal-gland-disorders/adrenal-insufficiency
[2.] Auchus RJ, Arlt W. Approach to the Patient: The Adult With Congenital Adrenal Hyperplasia. The Journal of Clinical Endocrinology and Metabolism. 2013;98(7):2645-2655. doi:https://doi.org/10.1210/jc.2013-1440
[3.] Chaudhry HS, Singh G. Cushing Syndrome. [Updated 2023 Jun 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470218/
[4.] Chustecka M, Blügental N, Majewski PM, Adamska I. 24 hour patterning in gene expression of pineal neurosteroid biosynthesis in young chickens (Gallus gallus domesticus L.). Chronobiol Int. 2021 Jan;38(1):46-60. doi: 10.1080/07420528.2020.1823404. Epub 2020 Sep 29. PMID: 32990093.
[5.] Cruz-Topete D, Oakley RH, Cidlowski JA. Glucocorticoid Signaling and the Aging Heart. Front Endocrinol (Lausanne). 2020 May 27;11:347. doi: 10.3389/fendo.2020.00347. PMID: 32528419; PMCID: PMC7266971.
[6.] Cushing syndrome: MedlinePlus Medical Encyclopedia. Medlineplus.gov. Published 2015. https://medlineplus.gov/ency/article/000410.htm
[7.] den Boon FS, de Vries T, Baelde M, Joëls M, Karst H. Circadian and Ultradian Variations in Corticosterone Level Influence Functioning of the Male Mouse Basolateral Amygdala. Endocrinology. 2019;160(4):791-802. doi:https://doi.org/10.1210/en.2018-00767
[8.] Gambineri A, Forlani G, Munarini A, Tomassoni F, Cognigni GE, Ciampaglia W, Pagotto U, Walker BR, Pasquali R. Increased clearance of cortisol by 5beta-reductase in a subgroup of women with adrenal hyperandrogenism in polycystic ovary syndrome. J Endocrinol Invest. 2009 Mar;32(3):210-8. doi: 10.1007/BF03346454. PMID: 19542736; PMCID: PMC4425940.
[9.] McInnes KJ, Kenyon CJ, Chapman KE, Livingstone DE, Macdonald LJ, Walker BR, Andrew R. 5alpha-reduced glucocorticoids, novel endogenous activators of the glucocorticoid receptor. J Biol Chem. 2004 May 28;279(22):22908-12. doi: 10.1074/jbc.M402822200. Epub 2004 Mar 24. PMID: 15044432.
[10.] Miller WL, Auchus RJ. The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders. Endocrine Reviews. 2011;32(1):81-151. doi:https://doi.org/10.1210/er.2010-0013
[11.] Montano MM, Wang MH, Even MD, vom Saal FS. Serum corticosterone in fetal mice: sex differences, circadian changes, and effect of maternal stress. Physiol Behav. 1991 Aug;50(2):323-9. doi: 10.1016/0031-9384(91)90073-w. PMID: 1745676.
[12.] Pediatric Adrenal Insufficiency (Addison Disease): Practice Essentials, Anatomy, Etiology. eMedicine. Published online January 12, 2022. https://emedicine.medscape.com/article/919077-overview
[13.] Rupa Health. HuMap Sample Report.pdf. Google Docs. Accessed June 14, 2024. https://drive.google.com/file/d/1-d5lSCZ2M1_5YYCfMSqxc6lvUU6fMcaZ/view
[14.] Spencer RL, Hutchison KE. Alcohol, aging, and the stress response. Alcohol Res Health. 1999;23(4):272-83. PMID: 10890824; PMCID: PMC6760387.
[15.] Tetrahydrocorticosterone (CHEBI:9481). www.ebi.ac.uk. Accessed June 16, 2024. https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:9481
[16.] Uslar T, Olmos R, Martínez-Aguayo A, Baudrand R. Clinical Update on Congenital Adrenal Hyperplasia: Recommendations from a Multidisciplinary Adrenal Program. J Clin Med. 2023 Apr 26;12(9):3128. doi: 10.3390/jcm12093128. PMID: 37176569; PMCID: PMC10179176.
[17.] Vassiliadi DA, Barber TM, Hughes BA, et al. Increased 5α-Reductase Activity and Adrenocortical Drive in Women with Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. 2009;94(9):3558-3566. doi:https://doi.org/10.1210/jc.2009-0837